Teladoc Health Makes A1C Testing Easier for Members with Diabetes

Go back to Teladoc Health Makes A1C Testing Easier for Members with Diabetes

Teladoc (TDOC) Initiated with Buy at DA Davidson After Establishing Leadership in Telehealth

August 12, 2022 2:00 PM EDT

DA Davidson analyst Robert Simmons initiated coverage of Teladoc (NYSE: TDOC) with a Buy rating and $45 price target in a research note to clients on Friday.

The analyst said they believe Teladoc has established itself as the leader in telehealth, with operational scale and completeness of... More